Delaware Federal Judge Upholds UCB's Epilepsy Drug Patent
A top federal judge in Delaware decided Wednesday that three generic-drug makers failed to prove a claim in a patent for an ingredient in a popular seizure drug should never have...To view the full article, register now.
Already a subscriber? Click here to view full article